Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.82 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.82 |
| ▸ | RAB9A | P51151 | 1/20 | 0.82 |
| ▸ | HTT | P42858 | 1/20 | 0.73 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.70 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.70 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 2/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.57 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30921173 | 1.00 | MEN1 (0.82) | MEN1KMT2ARAB9AHTTSLC22A6 | |
| SCHEMBL15289000 | 0.90 | MEN1 (1.00) | MEN1KMT2ARAB9AHTTSLC22A6 | |
| SCHEMBL29532454 | 0.90 | MEN1 (1.00) | MEN1KMT2ARAB9AHTTSLC22A6 | |
| SCHEMBL23829497 | 0.86 | MEN1 (0.83) | MEN1KMT2ARAB9AHTTSLC22A6 | |
| SCHEMBL310113 | 0.85 | MEN1 (0.82) | MEN1KMT2ARAB9AHTTSLC22A6 | |
| SCHEMBL10339186 | 0.85 | MEN1 (0.82) | MEN1KMT2ARAB9AHTTSLC22A6 | |
| SCHEMBL10339187 | 0.85 | MEN1 (0.82) | MEN1KMT2ARAB9AHTTSLC22A6 | |
| SCHEMBL30892512 | 0.85 | MEN1 (0.82) | MEN1KMT2ARAB9AHTTSLC22A6 | |
| SCHEMBL7820973 | 0.85 | MEN1 (0.59) | MEN1KMT2ARAB9AHTTSLC22A6 | |
| SCHEMBL339242 | 0.85 | CA12 (0.71) | MEN1KMT2ARAB9AHTTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2217093-B1 | FLAVOUR-MODULATING COMPOUNDS | GIVAUDAN SA (CH) | 2012-03-21 | — | — | EP | claimed |
| EP-2217093-A1 | FLAVOUR-MODULATING COMPOUNDS | Givaudan SA (CH) | 2010-08-18 | — | — | EP | claimed |
| WO-2009055953-A1 | FLAVOUR-MODULATING COMPOUNDS | GIVAUDAN SA (CH) | 2009-05-07 | — | — | WO | claimed |
| CN-120058496-A | Preparation method and application of vanillin | 浙江医药股份有限公司昌海生物分公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-115925524-B | Method for preparing vanillin from 4-methyl guaiacol | 安徽圣诺贝化学科技有限公司 | 2024-06-25 | — | — | CN | disclosed |
| WO-2024105255-A1 | METHOD FOR MANUFACTURING SYNTHETIC VANILLIN | DEASYL SA (CH) | 2024-05-23 | — | — | WO | disclosed |
| EP-4371971-A1 | METHOD FOR MANUFACTURING SYNTHETIC VANILLIN | Deasyl SA (CH) | 2024-05-22 | — | — | EP | disclosed |
| CN-117630266-A | Method for judging vanillin oxidation end point based on thin-layer chromatography | 重庆欣欣向荣精细化工股份有限公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-117305199-A | Recombinant bacterium and application thereof in synthesis of 4-hydroxy-3-methoxybenzoic acid | 杭州唯铂莱生物科技有限公司 | 2023-12-29 | — | — | CN | disclosed |
| CN-117304008-A | Vanillin synthesis and reaction progress monitoring method | 上海应用技术大学 | 2023-12-29 | — | — | CN | disclosed |
| US-20230022284-A1 | AN ELECTROCHEMICAL METHOD FOR PREPARING VANILLIN OR ITS DERIVATIVES | RHODIA OPERATIONS (FR) | 2023-01-26 | — | — | US | disclosed |
| EP-2217093-B1 | FLAVOUR-MODULATING COMPOUNDS | GIVAUDAN SA (CH) | 2012-03-21 | — | — | EP | disclosed |
| EP-2217093-A1 | FLAVOUR-MODULATING COMPOUNDS | Givaudan SA (CH) | 2010-08-18 | — | — | EP | disclosed |
| WO-2009055953-A1 | FLAVOUR-MODULATING COMPOUNDS | GIVAUDAN SA (CH) | 2009-05-07 | — | — | WO | disclosed |
| WO-2009055953-A1 | FLAVOUR-MODULATING COMPOUNDS | GIVAUDAN SA (CH) | 2009-05-07 | — | — | WO | disclosed |
| WO-2002044128-A2 | SALICYLATE ANALOGS AS INTERLEUKIN-4 ANTAGONISTS | SUNESIS PHARMACEUTICALS, INC. (US) | 2002-06-06 | — | — | WO | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
| US-4385006-A | Process for preparing aromatic nitriles | 501 SOCIETE FRANCAISE HOECHST (FR) | 1983-05-24 | — | — | US | disclosed |
| US-4384137-A | CATALYTIC OXIDATION WITH CUPRIC IONS | SOCIETE FRANCAISE HOECHST (FR) | 1983-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230022284-A1 | AN ELECTROCHEMICAL METHOD FOR PREPARING VANILLIN OR ITS DERIVATIVES | VRK1, COMT, VRK2 | MEN1 2728/4885KMT2A 3628/4885RAB9A 1587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.